Man Group
GLSI icon

Man Group’s Greenwich LifeSciences GLSI Stock Holding History

Man Group’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,068
Closed -$590K – 2467
2025
Q4 		$590K Buy
+28,068
New +$295K ﹤0.01% 1847
2024
Q3 		– Sell
-16,650
Closed -$287K – 2053
2024
Q2 		$287K Buy
16,650
+5,285
+47% +$77.2K ﹤0.01% 1795
2024
Q1 		$227K Buy
+11,365
New +$140K ﹤0.01% 1991

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Man Group's GLSI Position: Q1 2026 in Review

Man Group sold out of Greenwich LifeSciences (GLSI) in Q1 2026, closing a stake of 28,068 shares — an estimated $590K sold.

Man Group first reported a position in GLSI in Q1 2024 and held it in 3 quarters. The position peaked at $590K in Q4 2025. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Man Group reported no remaining Greenwich LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 28,068 Greenwich LifeSciences shares in Q1 2026, an estimated $590K.
  • Man Group first reported a position in Greenwich LifeSciences in Q1 2024 and held it in 3 quarters.
  • Man Group's Greenwich LifeSciences position peaked at $590K in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.